GHK-Cu: Mechanistic Overview
internal_protocol · preclinical · status: needs_provider_review
Metadata
Author: Axiom Knowledge Base
Citation: Internal reference summary compiled for the Axiom knowledge base (2026).
Embedding: pending
File: signed link
Summary (generated — provider review required)
GHK-Cu is a copper-binding tripeptide (glycyl-L-histidyl-L-lysine) with well-characterized roles in skin and tissue remodeling. Mechanism: modulates expression of genes involved in extracellular-matrix turnover, has antioxidant and anti-inflammatory effects, and supports wound healing and angiogenesis in models and cosmetic studies. Relevance: connective-tissue and skin repair contexts.
The original source document remains the source of truth. Generated summaries are not authoritative.
Linked assets (4) · phenotypes (0)
evidence_reference, mechanism, safety_reference, dosing_reference
Evidence claims (3) · review items (2)
mechanism · pending
Mechanism: modulates expression of genes involved in extracellular-matrix turnover, has antioxidant and anti-inflammatory effects, and supports wound healing and angiogenesis in models and cosmetic studies.
safety · pending
Safety: generally favorable in topical use; systemic human data are limited.
dosing · pending
Mechanistic background for provider review only — not a treatment recommendation or dosing guidance.
Extracted chunks (1)
70 approx tokens across 1 chunks.